These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 37445811)

  • 1. Behavioral Study of 3- and 5-Halocytisine Derivatives in Zebrafish Using the Novel Tank Diving Test (NTT).
    Farías-Cea A; Leal C; Hödar-Salazar M; Esparza E; Martínez-Duran L; Fuentes I; Iturriaga-Vásquez P
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Buspirone, chlordiazepoxide and diazepam effects in a zebrafish model of anxiety.
    Bencan Z; Sledge D; Levin ED
    Pharmacol Biochem Behav; 2009 Nov; 94(1):75-80. PubMed ID: 19643124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of alpha7 and alpha4beta2 nicotinic receptors in the nicotine-induced anxiolytic effect in zebrafish.
    Bencan Z; Levin ED
    Physiol Behav; 2008 Oct; 95(3):408-12. PubMed ID: 18671990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subchronic effects of plant alkaloids on anxiety-like behavior in zebrafish.
    Hawkey AB; Hoeng J; Peitsch MC; Levin ED; Koshibu K
    Pharmacol Biochem Behav; 2021 Aug; 207():173223. PubMed ID: 34197843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anxiolytic effects of nicotine in zebrafish.
    Levin ED; Bencan Z; Cerutti DT
    Physiol Behav; 2007 Jan; 90(1):54-8. PubMed ID: 17049956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The zebrafish (Danio rerio) anxiety test battery: comparison of behavioral responses in the novel tank diving and light-dark tasks following exposure to anxiogenic and anxiolytic compounds.
    Fontana BD; Alnassar N; Parker MO
    Psychopharmacology (Berl); 2022 Jan; 239(1):287-296. PubMed ID: 34651212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nicotinic Antagonist UFR2709 Inhibits Nicotine Reward and Decreases Anxiety in Zebrafish.
    Viscarra F; González-Gutierrez J; Esparza E; Figueroa C; Paillali P; Hödar-Salazar M; Cespedes C; Quiroz G; Sotomayor-Zárate R; Reyes-Parada M; Bermúdez I; Iturriaga-Vásquez P
    Molecules; 2020 Jun; 25(13):. PubMed ID: 32630020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The larval diving response (LDR): Validation of an automated, high-throughput, ecologically relevant measure of anxiety-related behavior in larval zebrafish (Danio rerio).
    Fontana BD; Parker MO
    J Neurosci Methods; 2022 Nov; 381():109706. PubMed ID: 36089166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of nicotinic acetylcholine receptor-activating alkaloids on anxiety-like behavior in zebrafish.
    Alzualde A; Jaka O; Latino DARS; Alijevic O; Iturria I; de Mendoza JH; Pospisil P; Frentzel S; Peitsch MC; Hoeng J; Koshibu K
    J Nat Med; 2021 Sep; 75(4):926-941. PubMed ID: 34264421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of water changes on stress and subject variation in a zebrafish (Danio rerio) anxiety-related task.
    Fontana BD; Alnassar N; Parker MO
    J Neurosci Methods; 2021 Nov; 363():109347. PubMed ID: 34478765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishing zebrafish as a model to study the anxiolytic effects of scopolamine.
    Hamilton TJ; Morrill A; Lucas K; Gallup J; Harris M; Healey M; Pitman T; Schalomon M; Digweed S; Tresguerres M
    Sci Rep; 2017 Nov; 7(1):15081. PubMed ID: 29118373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ritanserin-sensitive receptors modulate the prosocial and the anxiolytic effect of MDMA derivatives, DOB and PMA, in zebrafish.
    Ponzoni L; Sala M; Braida D
    Behav Brain Res; 2016 Nov; 314():181-9. PubMed ID: 27506653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zebrafish assessment of cognitive improvement and anxiolysis: filling the gap between in vitro and rodent models for drug development.
    Levin ED
    Rev Neurosci; 2011; 22(1):75-84. PubMed ID: 21615262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Housing conditions differentially affect physiological and behavioural stress responses of zebrafish, as well as the response to anxiolytics.
    Parker MO; Millington ME; Combe FJ; Brennan CH
    PLoS One; 2012; 7(4):e34992. PubMed ID: 22509375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anxiolytic-like effects of noribogaine in zebrafish.
    Kalueff AV; Kaluyeva A; Maillet EL
    Behav Brain Res; 2017 Jul; 330():63-67. PubMed ID: 28479267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative Analyses of Zebrafish Anxiety-Like Behavior Using Conflict-Based Novelty Tests.
    Kysil EV; Meshalkina DA; Frick EE; Echevarria DJ; Rosemberg DB; Maximino C; Lima MG; Abreu MS; Giacomini AC; Barcellos LJG; Song C; Kalueff AV
    Zebrafish; 2017 Jun; 14(3):197-208. PubMed ID: 28459655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leaves of Spondias mombin L. a traditional anxiolytic and antidepressant: Pharmacological evaluation on zebrafish (Danio rerio).
    Dos Santos Sampaio TI; de Melo NC; de Freitas Paiva BT; da Silva Aleluia GA; da Silva Neto FLP; da Silva HR; Keita H; Cruz RAS; Sánchez-Ortiz BL; Pineda-Peña EA; Balderas JL; Navarrete A; Carvalho JCT
    J Ethnopharmacol; 2018 Oct; 224():563-578. PubMed ID: 29852265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of exploratory behavior on physical activity in a common animal model of human disease, zebrafish (
    DePasquale C; Franklin K; Jia Z; Jhaveri K; Buderman FE
    Front Behav Neurosci; 2022; 16():1020837. PubMed ID: 36425283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anxiolytic effects of silibinin and naringenin on zebrafish model: A preclinical study.
    Nachammai V; Jeyabalan S; Muthusamy S
    Indian J Pharmacol; 2021; 53(6):457-464. PubMed ID: 34975133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiating the Neuropharmacological Properties of Nicotinic Acetylcholine Receptor-Activating Alkaloids.
    Alijevic O; Jaka O; Alzualde A; Maradze D; Xia W; Frentzel S; Gifford AN; Peitsch MC; Hoeng J; Koshibu K
    Front Pharmacol; 2022; 13():668065. PubMed ID: 35392565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.